ImmunityBio, Inc. (IBRX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 452.95M | 314.88M | 329.5M | 208.13M | 109.16M | 184.59M | 163.15M | 242.83M | 195.72M | 294.08M | 215.08M | 66.83M |
| Cash & Short-Term Investments | 380.88M | 242.82M | 257.81M | 153.66M | 61.59M | 149.81M | 130.37M | 217.98M | 170.5M | 266.46M | 189.8M | 45.95M |
| Cash Only | 205.19M | 88.33M | 60.24M | 137.66M | 60.66M | 143.43M | 111.97M | 130.1M | 133.03M | 265.45M | 177.96M | 43.51M |
| Short-Term Investments | 175.69M | 154.48M | 197.57M | 16M | 931K | 6.38M | 18.4M | 87.88M | 37.46M | 1.01M | 11.83M | 2.45M |
| Accounts Receivable | 43.27M | 42.62M | 32.03M | 22.33M | 17.45M | 2.65M | 4.9M | 2.06M | 2.14M | 3.17M | 2.33M | 3.28M |
| Days Sales Outstanding | 87.43 | 89.69 | 78 | 68.5 | 54.78 | 46.03 | 52.46 | 182.39 | 6.03K | 1.82K | 3.14K | 5.26K |
| Inventory | 547K | 0 | 0 | 6.64M | 8.44M | 8.27M | 1.96M | 1.81M | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 206.85 | - | - | 5.05K | 12.97K | - | - | - | - | - | - | - |
| Other Current Assets | 3.91M | 29.49M | 39.65M | 1.64M | 2.35M | 1.3M | 1.66M | 955K | 3.31M | 5.21M | 6.72M | 4.55M |
| Total Non-Current Assets | 193.68M | 187.02M | 189.49M | 193.94M | 194.6M | 198.35M | 201.42M | 201.5M | 204.96M | 210.37M | 217.34M | 224.4M |
| Property, Plant & Equipment | 146.07M | 147.54M | 0 | 167.73M | 167.05M | 170.46M | 174.23M | 175.77M | 178.71M | 182.68M | 187.81M | 194.04M |
| Fixed Asset Turnover | 0.30x | 0.26x | - | 0.16x | 0.10x | 0.04x | 0.03x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x |
| Goodwill | 910K | 910K | 910K | 910K | 910K | 0 | 910K | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 11.97M | 13.04M | 13.56M | 14.07M | 14.53M | 15.93M | 15.57M | 16.06M | 16.57M | 17.09M | 18.47M | 18.99M |
| Long-Term Investments | 10M | 10.48M | 8.02M | 0 | 0 | 0 | 0 | 0 | 0 | 891K | 817K | 841K |
| Other Non-Current Assets | 24.72M | 15.04M | 167M | 11.24M | 12.1M | 11.96M | 10.71M | 9.66M | 9.67M | 9.7M | 10.24M | 10.53M |
| Total Assets | 646.64M | 501.9M | 518.99M | 402.08M | 303.76M | 382.93M | 364.57M | 444.32M | 400.68M | 504.45M | 432.42M | 291.23M |
| Asset Turnover | 0.08x | 0.08x | 0.07x | 0.07x | 0.05x | 0.02x | 0.02x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | 112.88% | 31.07% | 42.36% | -9.51% | -24.19% | -24.09% | -15.69% | 52.57% | 16.68% | 39.21% | 22.52% | -8.34% |
| Total Current Liabilities | 67.95M | 61.75M | 57.13M | 50.64M | 49.2M | 54.94M | 60.96M | 62.11M | 53.76M | 58.28M | 90.32M | 613.48M |
| Accounts Payable | 11.19M | 6.98M | 5.77M | 7.42M | 13.5M | 6.72M | 9.95M | 20.32M | 13.87M | 9.2M | 19.82M | 25.49M |
| Days Payables Outstanding | 3.44K | 138.11 | 147 | 7K | 15.69K | - | - | - | - | - | - | - |
| Short-Term Debt | 8.56M | 9.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 518.51M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 36.94M | 25.42M | 43.6M | 17.02M | 12.18M | 15.98M | 18.1M | 13.54M | 9.29M | 18.31M | 15.97M | 25.09M |
| Current Ratio | 6.67x | 5.10x | 5.77x | 4.11x | 2.22x | 3.36x | 2.68x | 3.91x | 3.64x | 5.05x | 2.38x | 0.11x |
| Quick Ratio | 6.66x | 5.10x | 5.77x | 3.98x | 2.05x | 3.21x | 2.64x | 3.88x | 3.64x | 5.05x | 2.38x | 0.11x |
| Cash Conversion Cycle | -3.14K | - | - | -1.88K | -2.67K | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.45B | 939.72M | 985.26M | 921.25M | 845.04M | 816.12M | 1.05B | 1.08B | 1.04B | 1.03B | 752.74M | 322.93M |
| Long-Term Debt | 1.08B | 835.15M | 500.8M | 492.08M | 485.72M | 461.88M | 699.12M | 692.92M | 687.09M | 681.54M | 673.59M | 250.1M |
| Capital Lease Obligations | 33.36M | 33.67M | 34.37M | 35.84M | 33.1M | 34.82M | 36.76M | 36.43M | 38.2M | 39.94M | 39.31M | 44.56M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 331.77M | 70.89M | 450.33M | 393.33M | 326.22M | 319.42M | 311.89M | 350.25M | 312.62M | 310.63M | 39.84M | 28.27M |
| Total Liabilities | 1.52B | 1B | 1.04B | 971.89M | 894.24M | 871.06M | 1.11B | 1.14B | 1.09B | 1.09B | 843.06M | 936.41M |
| Total Debt | 1.12B | 878.12M | 542.25M | 535.32M | 526.27M | 504.17M | 742.91M | 735.59M | 731.37M | 726.72M | 717.27M | 819.16M |
| Net Debt | 919.41M | 789.78M | 482.01M | 397.66M | 465.61M | 360.74M | 630.95M | 605.49M | 598.33M | 461.27M | 539.3M | 775.65M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -2.45x | -1.28x | -1.44x | -2.20x | -3.50x | -2.97x | -1.13x | -2.45x | -2.73x | -6.27x | -1.73x | -3.29x |
| Total Equity | -869.13M | -499.57M | -523.41M | -569.82M | -590.48M | -488.13M | -744.16M | -697.38M | -690.98M | -585.94M | -410.64M | -645.18M |
| Equity Growth % | -47.19% | -2.34% | 29.66% | 18.29% | 14.54% | 16.69% | -81.22% | -8.09% | -29.95% | -30.26% | 4.3% | -52.9% |
| Book Value per Share | -0.85 | -0.50 | -0.55 | -0.64 | -0.69 | -0.66 | -1.07 | -1.02 | -1.03 | -0.99 | -0.82 | -1.47 |
| Total Shareholders' Equity | -870.01M | -499.57M | -524.32M | -570.75M | -591.43M | -489.1M | -745.15M | -698.39M | -692.01M | -586.99M | -411.72M | -642.12M |
| Common Stock | 104K | 101K | 98K | 91K | 85K | 85K | 70K | 69K | 68K | 67K | 67K | 44K |
| Retained Earnings | -4.36B | -3.73B | -3.66B | -3.6B | -3.5B | -3.38B | -3.32B | -3.23B | -3.1B | -2.96B | -2.73B | -2.63B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 27.45M | 28.96M | 5M | 12.57M | 19.96M | 1.2M | 103K | -8K | -7K | 10K | 792K | -40K |
| Minority Interest | 880K | 895K | 909K | 930K | 949K | 969K | 986K | 1.01M | 1.03M | 1.05M | 1.07M | -3.07M |